CEL-SCI Corp. (CVM) Operatsion marja

CEL-SCI Corporation - CVM emitenti grafik logotipi

CEL-SCI Corporation tijorat sotuvlarining yo'qligi sababli narxlarni belgilash imkoniyatiga ega emas. Kompaniyaga tegishli operatsiyalar bosh va bo'yin o'smalariga qarshi kurashish uchun immunoterapiyani ishlab chiqishga tayanadi. GURU.Markets platformasidagi choraklik operatsion marja daromadlilikni vizuallashtiradi, bunda 0.00 qiymati ushbu darajani xarakterlaydi. Istiqbollar Multikine test natijalari, FDA tasdig'i va bemorlarning yashab qolish ma'lumotlariga bog'liq.

CVM - CEL-SCI Corp. Operatsion foyda normasi 04.07.2022 - 19.11.2026 oraligʻida

CEL-SCI Corp (CVM) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:CVM, cel-sci.com
CEL-SCI Corp. asosiy tovari

Operatsion marja foizlar va soliqlar to'lovigacha bo'lgan operatsion foydani umumiy daromad bilan solishtirish orqali xarajatlarni boshqarish samaradorligini belgilaydi. Operatsion rentabellikni tahlil qilish orqali investor CEL-SCI Corporation immunoterapiya ishlab chiqarishidagi bioreaktor robotizatsiyasi va inson xatolarini minimallashtirish ichki xarajatlarni qanday optimallashtirishini hamda biznesning yakuniy fundamental qiymatiga bevosita ta'sir qilishini ko'rishi mumkin.

CEL-SCI Corporation kimlar bilan raqobatlashadi

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik ostherapies.com OSTX|RADX: Operatsion foyda bo'yicha sotuv rentabelligi|ARTV: Sotuvning operatsion marjasi|ANL (Adlai Nortye) - Operatsion foyda bo'yicha sotuv rentabelligi|Veru (VERU) - Operatsion rentabellik|Sotuvning operatsion marjasi Tempest Therapeutics Inc|Operatsion rentabellik Xilio Therapeutics|Operatsion foyda bo'yicha sotuv rentabelligi RENB (Renovaro Inc.)|Operatsion rentabellik Mural Oncology PLC (MURA)|Operatsion marja Kairos Pharma (KAPA)|Operatsion rentabellik onkuretherapeutics.com OKUR|GDTC: Operatsion foyda bo'yicha sotuv rentabelligi|CRIS: Sotuvning operatsion marjasi|apollomicsinc.com (APLM) - Sotuvning operatsion marjasi|THAR: Operatsion marja|Sotuvning operatsion marjasi Advanced Biomed Inc.|Sotuvning operatsion marjasi GNPX|Operatsion foyda bo'yicha sotuv rentabelligi CLDI (Calidi Biotherapeutics)|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja